Biological skin substitutes for wound cover and closure

References

• Horch RE, Kopp J, Kneser U, Beier J, Bach AD. Tissue engineering of cultured skin substrates.J. Cell. Mol. Med.9(3), 592–608 (2005).
   PubMed Web of Science ®Google Scholar
• Jones I, Currie L, Martin R. A guide to biological skin substitutes.Br. J. Plast. Surg.55, 185–193 (2002).
   PubMedGoogle Scholar
• Boyce ST. Design principles for composition and performance of cultured skin substitutes.Burns27, 523–533 (2001).
   PubMed Web of Science ®Google Scholar
• Trent JT, Falabella A, Eaglstein WH, Kirsner RS. Venous ulcers: pathophysiology and treatment options.Ostomy Wound Manage.51(5), 38–54 (2005).
   PubMed Web of Science ®Google Scholar
• Del Rio M, Gache Y, Jorcano JL, Meneguzzi G, Larcher F. Current approaches and perspective in human keratinocyte-based gene therapies.Gene Ther.11, S57–S63 (2004).
   PubMed Web of Science ®Google Scholar
• Haake A, Scott GA, Holbrook KA. Structure and function of the skin: overview of the epidermis and dermis. In:The Biology of the Skin. Freinkel RL, Woodley DT (Eds), The Parthenon Publishing Group Inc., NY, USA, 19–45 (2001).
   Google Scholar
• Sorrell JM, Caplan AI. Fibroblast heterogeneity: more than skin deep.J. Cell Sci.117(5), 667–675 (2004).
   PubMed Web of Science ®Google Scholar
• Silver FH, Freeman JW, DeVore D. Viscoelastic properties of human skin and processed dermis.Skin Res. Technol.7(1), 18–23 (2001).
   PubMed Web of Science ®Google Scholar
• Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing.Front. Biosci.9, 283–289 (2004).
   PubMed Web of Science ®Google Scholar
• Werner S, Grose R. Regulation of wound healing by growth factors and cytokines.Physiol. Rev.83, 835–870 (2003).
   PubMed Web of Science ®Google Scholar
• Grazul-Bilska AT, Johnson ML, Bilski JJ et al. Wound healing: the role of growth factors.Drugs Today39(10), 787–800 (2003).
   PubMed Web of Science ®Google Scholar
• Santoro MM, Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing.Exp. Cell Res.304, 274–286 (2005).
   PubMed Web of Science ®Google Scholar
• auf dem Keller U, Krampert M, Kumin A, Braun S, Werner S. Keratinocyte growth factor: effects on keratinocytes and mechanisms of action.Eur. J. Cell Biol.83(11–12), 607–612 (2004).
   Web of Science ®Google Scholar
• Greenwald SE, Berry CL. Improving vascular grafts: the importance of mechanical and hemodynamic properties.J. Pathol.190, 292–299 (2000).
   PubMed Web of Science ®Google Scholar
• Lee KH. Tissue-engineered human living skin substitutes: development and clinical application.Yonsei Med. J.41(6), 774–779 (2000).
   PubMed Web of Science ®Google Scholar
• O’Brien FJ, Harley BA, Yanna IV, Gibson LJ. The effect of pore size on cell adhesion in collagen-GAG scaffolds.Biomaterials26(4), 433–441 (2005).
   PubMed Web of Science ®Google Scholar
• Badiavas EV, Paquette D, Carson P, Falanga V. Human chronic wounds treated with bioengineered skin: histologic evidence of host–graft interactions.J. Am. Acad. Dermatatol.46(4), 524–530 (2002).
   PubMed Web of Science ®Google Scholar
• Atiyeh BS, Shady NH, Gunn SW. New technologies for burn wound closure and healing – review of the literature.Burns31, 944–956 (2005).
   PubMed Web of Science ®Google Scholar
• Snyder RJ. Treatment of nonhealing ulcers with allografts.Clin. Dermatol.23, 388–395 (2005).
   PubMed Web of Science ®Google Scholar
• Masahiro KO, Taya M. Development of culture techniques of keratinocytes for skin graft production.Adv. Biochem. Eng. Biotechnol.91, 135–169 (2004).
   Google Scholar
• Kearney JN. Guidelines on processing and clinical use of skin allografts.Clin. Dermatol.23, 357–364 (2005).
   PubMed Web of Science ®Google Scholar
• Supp DM, Boyce ST. Engineered skin substitutes: practices and potentials.Clin. Dermatol.23, 403–412 (2005).
   PubMed Web of Science ®Google Scholar
• Sibbald RG, Torrance GW, Walker V, Attard C, MacNeil P. Cost-effectiveness of Aplifraf in the treatment of venous leg ulcers.Ostomy Wound Manage.47(8), 36–46 (2001).
   Google Scholar
• Redekop WK, McDonnell J, Verboom P, Lovas K, Kalo Z. The cost effectiveness of Apligraf treatment of diabetic foot ulcers.Pharmacoeconomics21(16), 1171–1183 (2003).
   PubMed Web of Science ®Google Scholar
• Auger FA, Berthod F, Moulin V, Pouliot R, Germain L. Tissue-engineered skin substitutes: from in vitro constructs to in vivo applications.Biotechnol. Appl. Biochem.39, 263–275 (2004).
   Google Scholar
• Balasubramani M, Kumar TR, Babu M. Skin substitutes: a review.Burns27, 534–544 (2001).
   PubMed Web of Science ®Google Scholar
• Shakespeare PG. The role of skin substitutes in the treatment of burn injuries.Clin. Dermatol.23, 413–418 (2005).
   PubMed Web of Science ®Google Scholar
• Wainwright D, Madden M, Luterman A et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns.J. Burn Care Rehabil.17, 124–136 (1996).
   PubMedGoogle Scholar
• Lattari V, Jones LM, Varcelotti JR et al. The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases.J. Burn Care Rehabil.18, 147–155 (1997).
   PubMedGoogle Scholar
• Barrett JP, Dziewulski P, McCauley RL, Herndon DN, Desai MH. Dermal reconstruction of a class IV calvarial burn with decellularized human dermis.Burns25, 459–462 (1999).
   Google Scholar
• Gryskiewicz JM. Waste not, want not: the use of Alloderm in secondary rhinoplasy.Plast. Reconstr. Surg.116(7), 1999–2004 (2005).
   PubMedGoogle Scholar
• Li TG, Shorr N, Goldberg RA. Comparison of the efficacy of hard palate grafts with acellular human dermis grafts in lower eyelid surgery.Plast. Reconstr. Surg.116(3), 873–880 (2005).
   PubMedGoogle Scholar
• Haynes DS, Vos JD, Labadie RF. Acellular allograft dermal matrix for tympanoplasy.Curr. Opin. Otolaryngol. Head Neck Surg.13(5), 283–286 (2005).
   PubMedGoogle Scholar
• Omar AA, Mavor AI, Jones AM, Homer-Vanniasinkam S. Treatment of venous leg ulcers with Dermagraft.Eur J. Vasc. Endovasc. Surg.27(6), 666–672 (2004).
   PubMed Web of Science ®Google Scholar
• Marston WA, Hanft J, Norwood P, Pollak R; Dermagraft Diabetic Foot ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.Diabetes Care26(6), 1701–1715 (2003).
   PubMed Web of Science ®Google Scholar
• Hansbrough JF, Doré C, Hansbrough WB. Clinical trials of a living dermal tissue replacement beneath meshed, split-thickness skin grafts on excised burn wounds.J. Burn Care Rehabil.13, 519–529 (1992).
   PubMedGoogle Scholar
• Browne AC, Vearncombe M, Sibbald RG. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.Ostomy Wound Manage.47(10), 44–49 (2001).
   PubMedGoogle Scholar
• Brown-Etris M, Cutshall WD, Hiles MC. A new biomaterial derived from small intestine submucosa and developed into a wound matrix device.Wounds14(4), 150–166 (2002).
   Web of Science ®Google Scholar
• McDevitt CA, Wildey GM, Cutrone RM. Transforming growth factor-β1 in a sterilized tissue derived from the pig small intestine submucosa.J. Biomed. Mater. Res. A67, 637–640 (2003).
   PubMedGoogle Scholar
• Hodde JP, Ernst DM, Hiles MC. An investigation of the long-term bioactivity of endogenous growth factor in OASIS wound matrix.J. Wound Care14(1), 23–25 (2005).
   PubMedGoogle Scholar
• Santucci RA, Barber TD. Resorbable extracellular matrix grafts in urologic reconstruction.Int. Braz. J. Urol.31(3), 192–203 (2005).
   PubMedGoogle Scholar
• Demling RH, Niezgoda JA, Haraway GD, Mostow EN. Small intestinal submucosa wound matrix and full-thickness venous ulcers: preliminary results.Wounds16(1), 18–22 (2004).
   Web of Science ®Google Scholar
• Mostow EN, Haraway DO, Dalsing M, Hodde JP, King D, OASIS Venus Study Group. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial.J. Vasc. Surg.41(5), 837–843 (2005).
   PubMed Web of Science ®Google Scholar
• Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP, OASIS Diabetic Ulcer Study Group. Randomized clinical trail comparing OASIS wound matrix to Regranex gel diabetic ulcers.Adv. Skin Wound Care18(5), 258–266 (2005).
   PubMedGoogle Scholar
• Lal S, Barrow RE, Wolf SE et al. Biobrane improves wound healing in burned children without increased risk of infection.Shock14(30), 318–319 (2000).
   Google Scholar
• Yannas IV, Burke JF, Orgill DP. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin.Science215, 174–176 (1982).
   PubMed Web of Science ®Google Scholar
• Burke JF, Yannas IV, Quinby WS, Bondoc CC, Jung WK. Successful use off a physiologically acceptable artificial skin in the treatment of extensive burn injury.Ann. Surg.194, 413–428 (1981).
   PubMed Web of Science ®Google Scholar
• Ruszczak Z. Effect of collagen matrices on dermal wound healing.Adv. Drug Deliv. Rev.55(12), 1595–1611 (2003).
   PubMed Web of Science ®Google Scholar
• Heimbach D, Luterman A, Burke J et al. Artificial dermis for major burns: multi-center randomized clinical trial.Ann. Surg.208, 313–320 (1998).
   Google Scholar
• Sheridan RL, Hegarty M, Tompkins RG, Burke JF. Artificial skin in massive burns – results to ten years.Eur. J. Plast. Surg.17, 91–93 (1994).
   Google Scholar
• Stern R, McPherson M, Longaker MT. Histologic study of artificial skin used in the treatment of full-thickness thermal injury.J. Burn Care Rehabil.11(1), 7–13 (1990).
   PubMedGoogle Scholar
• Komorowska-Timek E, Gabriel A, Bennett DC et al. Artificial dermis as an alternative for coverage of complex scalp defects following excision of malignant tumors.Plast. Reconstr. Surg.115(4), 1010–1017 (2005).
   PubMed Web of Science ®Google Scholar
• Jeschke MG, Rose C, Angele P, Fuchtmeier B, Nerlich MN, Bolder U. Development of new reconstructive techniques: use of Integra in combination with fibrin glue and negative-pressure therapy for reconstruction of acute and chronic wounds.Plast. Reconstr. Surg.113(2), 525–530 (2004).
   PubMed Web of Science ®Google Scholar
• Edlich RF, Winters KL, Woodard CR, Britt LD, Long WB III. Massive soft tissue infections: necrotizing fasciitis and purpura fulminans.J. Long Term Eff. Med. Implants15(1), 57–65 (2005).
   Google Scholar
• Schulz JT III, Tompkins RG, Burke JF. Artificial skin.Annu. Rev. Med.51, 231–244 (2000).
   Google Scholar
• Kremer M, Lang E, Berger AC. Evaluation of dermal–epidermal skin equivalents (‘composite-skin’) of human keratinocytes in a collagen–glycosaminoglycan matrix (Integra artificial skin).Br. J. Plast. Surg.53(6) 459–465 (2000).
   PubMedGoogle Scholar
• Hansbrough JF, Mozingo DW, Kealey GP, Davis M, Gidner A, Gentzkow GD. Clinical trails of a biosynthetic temporary skin replacement, Dermagraft-Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds.J. Burn Care Rehabil.18(1), 43–51 (1997).
   PubMedGoogle Scholar
• Purdue GF, Hunt JL, Still JM Jr et al. A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds.J. Burn Care Rehabil.18(1), 52–57 (1997).
   PubMedGoogle Scholar
• Lukish JR, Eichelberger MR, Newman KD et al. The use of a bioactive skin substitute decreases length of stay for pediatric burn patients.J. Pediatr. Surg.36(8), 1118–1121 (2001).
   PubMed Web of Science ®Google Scholar
• Kumar RJ, Kimble RM, Boots R, Pegg SP. Treatment of partial-thickness burns: a prospective, randomized trial using TransCyte™.ANZ J. Surg.74, 622–626 (2004).
   PubMed Web of Science ®Google Scholar
• Hardin-Young J, Parenteau N. Bilayered skin constructs. In:Methods of Tissue Engineering. Atala A, Lanza RP (Eds), Academic Press, CA, USA, 1177–1188 (2002).
   Google Scholar
• Falanga V, Margolis DJ, Alvarez O et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent.Arch. Dermatol.134, 293–300 (1998).
   PubMed Web of Science ®Google Scholar
• Sabolinkski ML, Alvarez O, Auletta M, Mulder G, Parenteau NL. Cultured skin as a “smart material” for healing wounds: experience in venous ulcers.Biomaterials17, 311–320 (1996).
   Google Scholar
• Curran MP, Plosker GL. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.BioDrugs16, 439–455 (2002).
   PubMed Web of Science ®Google Scholar
• Falabella AF, Valencia IC, Eaglstein WH et al. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds.Arch. Dermatol.136, 1225–1230 (2000).
   PubMed Web of Science ®Google Scholar
• Fivenson DP, Scherschun L, Choueair M, KuKuruga D, Young J, Shwayder T. Graftskin therapy in epidermolysis bullosa.J. Am. Acad. Dermatol.48(6), 886–892 (2003).
   PubMed Web of Science ®Google Scholar
• Abai B, Thayer D, Glat PM. Two cases of traumatic wounds in patients with Ehlers–Danlos Syndrome successfully treated with a bioengineered skin equivalent.Wounds15(6), 201–207 (2003).
   Google Scholar
• Eaglestein WH, Iriondo M, Laszlo K. A composite skin substitute (Graftskin) for surgical wounds. A clinical experience.Dermatol. Surg.21, 839–843 (1995).
   Google Scholar
• Waymack P, Duff RG, Sabolinski M. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds.Burns26, 609–619 (2000).
   PubMed Web of Science ®Google Scholar
• Griffiths M, Ojeh N, Livingstone R, Price R, Navsaria H. Survival of Apligraf in acute human wounds.Tissue Eng.10(7–8), 1180–1195 (2004).
   PubMedGoogle Scholar
• Schonfeld WH, Villa KF, Fasenau JM, Mazonson PD, Falanga V. An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers.Wound Repair Regen.8(4), 251–257 (2000).
   Google Scholar
• Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells.Cell6, 331–343 (1975).
   PubMed Web of Science ®Google Scholar
• Lam PK, Chan ES, Liew CT, Lau CH, Yen SC, King WW. Combination of a new composite biocompatible skin graft on the neodermis of artificial skin in an animal model.ANZ J. Surg.72, 360–363 (2002).
   PubMedGoogle Scholar
• Lobmann R, Pittasch D, Mühlen I, Lehnert H. Autologous human keratinocytes culture on membranes composed of benzyl ester of hyaluronic acid for grafting in nonhealing diabetic foot leasions: a pilot study.J. Diabetes Complicat.17(4), 199–204 (2003).
   PubMed Web of Science ®Google Scholar
• Eisenbud D, Huang NF, Luke S, Silberklang S. Skin substitutes in wound healing: current status and challenges.Wounds16(1), 2–17 (2004).
   Web of Science ®Google Scholar
• Compton CC. Current concepts in pediatric burn care: the biology of cultured epithelial autografts: an eight-year study in pediatric burn patients.Eur. J. Pediatr. Surg.2, 216–222 (1992).
   PubMed Web of Science ®Google Scholar
• Carsin H, Ainaud P, Le Bever H et al. Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients.Burns26, 379–387 (2000).
   PubMed Web of Science ®Google Scholar
• Swope VB, Supp AP, Boyce ST. Regulation of cutaneous pigmentation by titration of human melanocytes in cultured skin substitutes grafted to athymic mice.Wound Repair Regen.10(6), 378–386 (2002).
   PubMed Web of Science ®Google Scholar
• Jones I, James SE, Rubin P, Martin R. Upward migration of cultured autologous keratinocytes in Integra artificial skin: a preliminary report.Wound Repair Regen.11(2), 132–138 (2003).
   Google Scholar
• Izumi K, Feinberg SE, Terashi H, Marcelo CL. Evaluation of transplanted tissue-engineered oral mucosa equivalents in severe combined immunodeficient mice.Tissue Eng.9(1), 163–174 (2003).
   Google Scholar
• Badylak SF, Record R, Lindberg K, Hodde J, Park K. Small intestinal submucosa: a substrate for in vitro cell growth.J. Biomater. Sci. Polym. Ed.9(8), 863–878 (1998).
   PubMed Web of Science ®Google Scholar
• Supp DM, Karpinski AC, Boyce ST. Vascular endothelial growth factor overexpression increases vascularization by murine but not human endothelial cells in cultured skin substitutes grafted to athymic mice.J. Burn Care Rehabil.25(4), 337–345 (2004).
   Google Scholar
• Hüsing B, Bürken B, Gaisser S. Human tissue engineered products – today’s market and future prospects. Fraunhofer Institute for Systems Innovation and Research. Karlsruhe, Germany (2004).
   Google Scholar